Author: OurCrowd

[SaNOtize in Asia One] BuyEnov unveils the long-term Safety and efficacy profile of SaNOtize Nasal Spray: Key insights revealed

BuyEnov, a pioneering force in medication logistics headquartered in Israel, continues its commitment to enhancing healthcare accessibility worldwide. Proudly continuing its global distribution, the company reaffirms the availability of its ground-breaking antiviral treatment, SaNOtize—Nitric Oxide Nasal Spray (NONS). Read more...

Read More

[Nexa3D in BusinessWire] EasyRx announces integration with Nexa3D’s line of 3D printers

ATLANTA–(BUSINESS WIRE)–EasyRx, a leader in universal lab prescription, digital workflow, and 3D software for dentists and orthodontists, is excited to announce its collaboration with Nexa3D, a pioneer in 3D printing and digital dentistry. By partnering with Nexa3D, EasyRx now integrates Nexa3D’s additive manufacturing technology into its digital workflow, resulting in a more efficient and streamlined experience for dental labs and practices. This collaboration not only meets the demands of users for an integrated and high-tech workflow, but also sets a new standard for patient care by combining EasyRx’s platform with Nexa3D’s 3D printing solutions. Read...

Read More

[PRESS RELEASE] OurCrowd Announces First Close of Israel Resilience Fund, with 8 Initial Investments, to Support Israel’s Tech Sector at Time of Crisis

December 20, 2023 – JERUSALEM – OurCrowd, a leading global digital investment platform, today announced the first close of its $50M Israel Resilience Fund, with more than $13M in capital commitments, and approved the first 8 investments from the fund. OurCrowd will waive all management fees and carried interest as a contribution to Israel’s current wartime emergency. The fund, which was first announced just 40 days ago, becomes one of the fastest-closing venture funds ever to go from conception to closure and 8 actual investments, according to OurCrowd. Read more...

Read More